This content is from: Culture What Is Bill Ackman Up To? The failure of Silicon Valley Bank and the looming bank crisis is fueling the hedge fund manager’s new passion: Twitter. By Michelle Celarier March 21, 2023
This content is from: Portfolio Can Bill Ackman Still Turn 2022 Around? Pershing Square notched an 8 percent return in November. By Michelle Celarier December 02, 2022
Sponsored Valeant Looks To Refinance Loans Valeant Pharmaceuticals International Inc. is seeking to refinance the existing senior secured credit facilities of its wholly owned subsidiary Valeant Pharmaceuticals International. September 21, 2011
Sponsored Valeant Offers $5.7B For Cephalon Ontario-based Valeant Pharmaceuticals International is seeking to acquire drug maker, Cephalon, for nearly $5.7 billion. March 29, 2011
Sponsored Valeant To Issue $1.5B In Debt Valeant Pharmaceuticals International will sell senior unsecured notes worth $1.5 billion. March 07, 2011
Sponsored Valeant To Buy PharmaSwiss For €350M Canadian specialty pharmaceutical company, Valeant Pharmaceuticals International, will acquire PharmaSwiss for €350 million. February 02, 2011
